Paul Rutherford Carter - Net Worth and Insider Trading

Paul Rutherford Carter Net Worth

The estimated net worth of Paul Rutherford Carter is at least $4 Million dollars as of 2024-04-19. Paul Rutherford Carter is the EVP Commercial Ops of Gilead Sciences Inc and owns about 62,305 shares of Gilead Sciences Inc (GILD) stock worth over $4 Million. Details can be seen in Paul Rutherford Carter's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul Rutherford Carter has not made any transactions after 2016-08-01 and currently still holds the listed stock(s).

Transaction Summary of Paul Rutherford Carter

Paul Rutherford Carter Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul Rutherford Carter owns 4 companies in total, including Mallinckrodt PLC (MNKKQ) , Alder BioPharmaceuticals Inc (ALDR) , and Gilead Sciences Inc (GILD) among others .

Click here to see the complete history of Paul Rutherford Carter’s form 4 insider trades.

Insider Ownership Summary of Paul Rutherford Carter

Ticker	Comapny	Transaction Date	Type of Owner
MNKKQ	Mallinckrodt PLC	2022-06-16	director
ALDR	Alder BioPharmaceuticals Inc	2019-10-22	director
GILD	Gilead Sciences Inc	2016-08-01	EVP Commercial Ops
MCKPF	Mallinckrodt PLC	2022-06-16	director

Paul Rutherford Carter Latest Holdings Summary

Paul Rutherford Carter currently owns a total of 1 stock. Paul Rutherford Carter owns 62,305 shares of Gilead Sciences Inc (GILD) as of August 1, 2016, with a value of $4 Million.

Latest Holdings of Paul Rutherford Carter

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
GILD	Gilead Sciences Inc	2016-08-01	62,305	66.76	4,159,482

Holding Weightings of Paul Rutherford Carter

Paul Rutherford Carter Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul Rutherford Carter has made a total of 0 transactions in Gilead Sciences Inc (GILD) over the past 5 years. The most-recent trade in Gilead Sciences Inc is the sale of 2,000 shares on August 1, 2016, which brought Paul Rutherford Carter around $159,620.

Insider Trading History of Paul Rutherford Carter

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul Rutherford Carter Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Paul Rutherford Carter Ownership Network

Ownership Network List of Paul Rutherford Carter

No Data

Ownership Network Relation of Paul Rutherford Carter

Paul Rutherford Carter Owned Company Details

What does Mallinckrodt PLC do?

Who are the key executives at Mallinckrodt PLC?

Paul Rutherford Carter is the director of Mallinckrodt PLC. Other key executives at Mallinckrodt PLC include director & President and CEO Sigurdur O Olafsson , 10 percent owner Fyi S.a R.l. , and 10 percent owner Ffi Iii S.a R.l. .

Mallinckrodt PLC (MNKKQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MNKKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC (MNKKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Mallinckrodt PLC (MNKKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mallinckrodt PLC Insider Transactions

No Available Data

What does Alder BioPharmaceuticals Inc do?

Who are the key executives at Alder BioPharmaceuticals Inc?

Paul Rutherford Carter is the director of Alder BioPharmaceuticals Inc. Other key executives at Alder BioPharmaceuticals Inc include 10 percent owner H Lundbeck A S , Chief Medical Officer Paul Streck , and Chief Financial Officer Carlos Campoy .

Alder BioPharmaceuticals Inc (ALDR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alder BioPharmaceuticals Inc (ALDR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alder BioPharmaceuticals Inc (ALDR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alder BioPharmaceuticals Inc (ALDR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alder BioPharmaceuticals Inc Insider Transactions

No Available Data

What does Gilead Sciences Inc do?

Who are the key executives at Gilead Sciences Inc?

Paul Rutherford Carter is the EVP Commercial Ops of Gilead Sciences Inc. Other key executives at Gilead Sciences Inc include Chief Medical Officer Merdad Parsey , EVP & Chief Financial Officer Andrew D Dickinson , and Chief Commercial Officer Johanna Mercier .

Gilead Sciences Inc (GILD) Insider Trades Summary

Over the past 18 months, Paul Rutherford Carter made no insider transaction in Gilead Sciences Inc (GILD). Other recent insider transactions involving Gilead Sciences Inc (GILD) include a net sale of 34,326 shares made by Merdad Parsey , a net sale of 15,000 shares made by Andrew D Dickinson , and a net sale of 22,671 shares made by Diane E. Wilfong .

In summary, during the past 3 months, insiders sold 12,230 shares of Gilead Sciences Inc (GILD) in total and bought 0 shares, with a net sale of 12,230 shares. During the past 18 months, 80,239 shares of Gilead Sciences Inc (GILD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 80,239 shares.

Gilead Sciences Inc (GILD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Gilead Sciences Inc Insider Transactions

No Available Data

What does Mallinckrodt PLC do?

Who are the key executives at Mallinckrodt PLC?

Paul Rutherford Carter is the director of Mallinckrodt PLC. Other key executives at Mallinckrodt PLC include 10 percent owner Alta Fundamental Advisers Llc , EVP & Head of Corp Development Jason Daniel Goodson , and EVP & Head of Spec Generics Stephen Andrew Welch .

Mallinckrodt PLC (MCKPF) Insider Trades Summary

Over the past 18 months, Paul Rutherford Carter made no insider transaction in Mallinckrodt PLC (MCKPF). Other recent insider transactions involving Mallinckrodt PLC (MCKPF) include a net purchase of 30,000 shares made by James R Sulat , a net purchase of 5,000 shares made by Paul Bisaro , and a net purchase of 3,000 shares made by Sigurdur O Olafsson .

In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MCKPF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC (MCKPF) were sold and 40,133 shares were bought by its insiders, resulting in a net purchase of 40,133 shares.

Mallinckrodt PLC (MCKPF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mallinckrodt PLC Insider Transactions

No Available Data

Paul Rutherford Carter Mailing Address

Above is the net worth, insider trading, and ownership report for Paul Rutherford Carter. You might contact Paul Rutherford Carter via mailing address: South Building, 2 Roundwood Avenue, Stockley Park X0 Ub11 1af.

Discussions on Paul Rutherford Carter

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Data is updated daily.